Advertisement
Advertisement
May 14, 2014
Boston Scientific to Acquire Bayer Interventional
May 15, 2014—Boston Scientific Corporation announced it has entered into a definitive agreement to acquire the Interventional Division of Bayer AG for $415 million in cash, including fees for transitional services. The company expects to close the transaction in the second half of 2014, subject to customary closing conditions.
Bayer Interventional will become part of the existing Boston Scientific Peripheral Interventions business. Bayer Interventional is based near Minneapolis, Minnesota and has approximately 350 employees.
According to Boston Scientific, the addition of Bayer Interventional supports the company’s strategy to provide a comprehensive portfolio of solutions to treat peripheral vascular disease.
Bayer Interventional technologies are designed to treat coronary and peripheral vascular disease. The transaction includes Bayer Interventional’s AngioJet thrombectomy system, the Fetch 2 aspiration catheter, and the JetStream peripheral atherectomy system.
Advertisement
Advertisement
